Francesco Giansanti
Overview
Explore the profile of Francesco Giansanti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
488
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bibbo S, Capone E, Lovato G, Ponziani S, Lamolinara A, Iezzi M, et al.
J Control Release
. 2024 Aug;
374:171-180.
PMID: 39128771
MYC is one of the most important therapeutic targets in human cancer. Many attempts have been made to develop small molecules that could be used to curb its activity in...
2.
Capone E, Perrotti V, Cela I, Lattanzio R, Togni L, Rubini C, et al.
Oral Oncol
. 2023 Nov;
148:106635.
PMID: 37988837
Objectives: Adenoid cystic carcinoma (ACC) is a rare type of cancer that typically arises from glandular tissues, most commonly in the salivary glands. Although relatively rare, it represents a serious...
3.
Dufrusine B, Capone E, Ponziani S, Lattanzio R, Lanuti P, Giansanti F, et al.
Mol Oncol
. 2023 May;
17(8):1460-1473.
PMID: 37195369
Glioblastoma multiforme (GBM) is a lethal disease characterized by an overall survival of about 1 year, making it one of the most aggressive tumours, with very limited therapeutic possibilities. Specific...
4.
Fata F, Gabriele F, Angelucci F, Ippoliti R, di Leandro L, Giansanti F, et al.
Sensors (Basel)
. 2023 Jan;
23(2).
PMID: 36679744
The demonstration of the first enzyme-based electrode to detect glucose, published in 1967 by S. J. Updike and G. P. Hicks, kicked off huge efforts in building sensors where biomolecules...
5.
Gallo V, Giansanti F, Arienzo A, Antonini G
J Funct Foods
. 2022 Jan;
89:104932.
PMID: 35003332
Native and chemically modified whey proteins and their peptide derivatives are encountering the interest of nutraceutical and pharmaceutical industries, due to the numerous properties, ranging from antimicrobial to immunological and...
6.
di Leandro L, Giansanti F, Mei S, Ponziani S, Colasante M, Ardini M, et al.
Front Pharmacol
. 2021 May;
12:588306.
PMID: 33935695
A novel suicide gene therapy approach was tested in U87 MG glioblastoma multiforme cells. A 26nt G-rich double-stranded DNA aptamer (AS1411) was integrated into a vector at the 5' of...
7.
Castelli V, Giordano A, Benedetti E, Giansanti F, Quintiliani M, Cimini A, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33477367
Cancer is one of the primary causes of death worldwide. Tumour malignancy is related to tumor heterogeneity, which has been suggested to be due to a small subpopulation of tumor...
8.
DAgostino D, Gentile R, Ponziani S, Di Vittorio G, Dituri F, Giannelli G, et al.
Oncol Rep
. 2021 Jan;
45(2):776-785.
PMID: 33416143
Liver cancer (LC) is an aggressive disease with a markedly poor prognosis. Therapeutic options are limited, and, until recently the only FDA‑approved agent for first‑line treatment of patients with LC...
9.
Ardini M, Bellelli A, Williams D, di Leandro L, Giansanti F, Cimini A, et al.
Bioconjug Chem
. 2021 Jan;
32(1):43-62.
PMID: 33411522
Morpheeins are proteins that reversibly assemble into different oligomers, whose architectures are governed by conformational changes of the subunits. This property could be utilized in bionanotechnology where the building of...
10.
Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33076448
Neuroblastoma is the most common extra-cranial solid tumor in infants and children, which accounts for approximately 15% of all cancer-related deaths in the pediatric population. New therapeutic modalities are urgently...